Article
Targeted oncogenesis reveals a distinct tissue-specific utilization of alternative promoters of the human mineralocorticoid receptor gene in transgenic mice.
The Journal of biological chemistry - 17 Mar 2000
Le Menuet D, Viengchareun S, Penfornis P, Walker F, Zennaro M C, Lombès M
Abstract excerpt
The human mineralocorticoid receptor (hMR) is a nuclear receptor mediating aldosterone action, whose expression is driven by two alternative promoters, P1 and P2, flanking the two first 5'-untranslated exons. In vivo characterization of hMR regulatory regions was performed by targeted oncogenesis in mice using P1 or P2 directing expression of the large T antigen of SV40 (TAg). While transgenic P1.TAg founders...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
